-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on CVS Health, Lowers Price Target to $108

Benzinga·11/16/2026 15:10:12
RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.